Circulating Tumor DNA Assays in Clinical Cancer Research

The importance of circulating free DNA (cfDNA) in cancer clinical research was recognized in 1994 when a mutated RAS gene fragment was detected in a patient’s blood sample. Up to 1% of the total circulating DNA in patients with cancer is circulating tumor DNA (ctDNA) that originates from tumor cells...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Natl Cancer Inst
Autori principali: Ossandon, Miguel R, Agrawal, Lokesh, Bernhard, Eric J, Conley, Barbara A, Dey, Sumana M, Divi, Rao L, Guan, Ping, Lively, Tracy G, McKee, Tawnya C, Sorg, Brian S, Tricoli, James V
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2018
Soggetti:
Commentary
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6136923/
https://ncbi.nlm.nih.gov/pubmed/29931312
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djy105
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi